See every side of every news story

Published 3 days ago • loading... • Updated 3 days ago

Cagent Vascular Receives $15M in Growth Capital From Trinity Capital

Summary by Citybiz

Cagent Vascular, a Wayne, PA-based developer of serration technology for vessel dilation in endovascular interventions, received $15M in growth capital from Trinity Capital (NASDAQ: TRIN). This capital augmented $45M of equity financing led by US Venture Partners in 2024. The company intends to use the funds to expand operations and its business reach. Led by CEO Brian Walsh, Cagent Vascular is a medical device company providing a vascular treat…

This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

1 Articles

All

Left

Center

Right

Cagent Vascular Receives $15M in Growth Capital From Trinity Capital

Cagent Vascular, a Wayne, PA-based developer of serration technology for vessel dilation in endovascular interventions, received $15M in growth capital from Trinity Capital (NASDAQ: TRIN). This capital augmented $45M of equity financing led by US Venture Partners in 2024. The company intends to use the funds to expand operations and its business reach. Led by CEO Brian Walsh, Cagent Vascular is a medical device company providing a vascular treat…

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Stories disproportionately reported by the Left or the Right

Coverage Details

Total News Sources1

Leaning Left0Leaning Right0Center0Last Updated2 days agoBias Distribution

No sources with tracked biases.

Bias Distribution

There is no tracked Bias information for the sources covering this story.

Untracked bias

Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

citybiz broke the news in 3 days ago on Friday, February 21, 2025.

Sources are mostly out of (0)

Similar News Topics

Stories disproportionately reported by the Left or the Right

Similar News Topics